Marder WD et al. Editorial: The present and future adequacy of rheumatology manpower: A study of health care needs and physician supply. Arth Rheum1991; 34: 1209-1217.
2.
White KP, Speechley M., Harth M., Ostbye T.Fibromyalgia in rheumatology practice: a survey of Canadian rheumatologists . J Rheumatol1995; 22: 722-726.
3.
Bennett RMFibromyalgia and the disability dilemma. A new era in understanding a complex, multidimensional pain syndrome. Arthritis Rheum1996; 39: 1627-1634.
4.
Wallace DJ, Schwartz E., Chi-Lin H, Peter JB. The 'rule out lupus' rheumatology consultation: clinical outcomes and perspectives. J Clin Rheumatol1995; 1: 158-164.
5.
Middleton GD , McFarlin JE, Lipsky PEThe prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum1994; 37: 1181-1188.
6.
Morand EF, Miller MH, Whittingham S., Littlejohn GOFibromyalgia syndrome and disease activity in systemic lupus erythematosus . Lupus1994; 3: 187-191.
7.
Wysenbeek AJ , Leibovici L., Amit M., Weinberger A.Disease patterns of patients with systemic lupus erythematosus as shown by application of factor analysis. J Rheumatol1992; 19: 1096-1099.
Vitali C. et al. Fibromyalgia features in patients with primary Sjögren's syndrome. Evidence of a relationship with psychological depression. Scand J Rheumatol1989; 18: 21-27.
10.
Bonafede RP , Downey DC, Bennett RMAn association of fibromyalgia with primary Sjögren's syndrome: a prospective study of 72 patients. J Rheumatol1995; 22: 133-136.
11.
Calvo-Alen J. et al. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum1995; 38: 1475-1484.
12.
Bennett RMConfounding features of the fibromyalgia syndrome: A current perspective of differential diagnosis. J Rheumatol1989; 16 (suppl 19): 58-61.
13.
Wolfe F. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum1990; 33: 160-172.
Yunus MB, Berg BC, Masi ATMultiphase skeletal scintigraphy in primary fibromyalgia syndrome: A blinded study. J Rheumatol1989; 16: 1466-1468.
16.
Bengtsson A. et al. Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scand J Rheumatol1986; 15: 340-347.
17.
Bennett RM et al. Symptoms of Raynaud's syndrome in patients with fibromyalgia. A study utilizing the Nielsen test, digital photoplethysmography, and measurements of platelet alpha 2-adrenergic receptors. Arthritis Rheum1991; 34: 264-269.
18.
Caro XJImmunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis Rheum1984; 27: 1174-1179.
19.
Caro XJ, Wolfe F., Johnston WH, Smith ALA controlled and blinded study of immunoreactant deposition at the dermal-epidermal junction of patients with primary fibrositis syndrome. J Rheumatol1986; 13: 1086-1092.
20.
Dinerman H. , Goldenberg DL, Felson DTA prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol1986; 13: 368-373.
21.
Petri M.Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol1995; 7: 395-401.
22.
Yunus MB, Hussey FX, Aldag JCAntinuclear antibodies and connective disease features in fibromyalgia syndrome: a controlled study. J Rheumatol1993; 20: 1557-1560.
23.
Bengtsson A. , Ernerudh J., Vrethem M., Skogh T.Absence of autoantibodies in primary fibromyalgia . J Rheumatol1990; 17: 1682-1683.
24.
Barkhuizen A., Schoeplin GS, Bennett RMFibromyalgia: a prominent feature in patients with musculoskeletal problems in chronic hepatitis C: a report of 12 patients . J Clin Rheumatol1996; 2: 180-184.
25.
Lovy MR, Starkebaum G., Uberoi S.Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol1996; 23: 979-983.
26.
Simms RW et al. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med1992; 92: 368-374.
27.
Buskila D. et al. Fibromyalgia in human immunodeficiency virus infection. J Rheumatol1990; 17: 1202-1206.
28.
Sigal LHPersisting complaints attributed to chronic lyme disease: possible mechanisms and implications for management. Am J Med1994; 96: 365-373.
29.
Steere AC, Taylor E., McHugh GL, Logigian ELThe overdiagnosis of Lyme disease. JAMA1993 ; 269: 1812-1816.
Schned ES, Williams DNSpecial concerns in Lyme disease. Seropositivity with vague symptoms and development of fibrositis. Postgrad Med1992; 91: 65-68, 70.
32.
Mariette X. et al. Heptatitis C virus and Sjögren's syndrome . Arthritis Rheum1993; 36: 280-281.
33.
Bengtsson A. , Backman E., Lindblom B., Skogh T.Long term follow-up of fibromyalgia patients: clinical symptoms, muscular function, laboratory tests—an eight year comparison study. J Musculoskeletal Pain1994 ; 2: 67-80.
34.
Kennedy M., Felson DTA prospective long-term study of fibromyalgia syndrome. Arthritis Rheum1996; 39: 682-685.
Dixon RP, Christy NPOn the various forms of corticosteroid withdrawal syndrome. Am J Med1980; 68: 224-229.
37.
Clark S., Tindall E., Bennett RMA double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol1985; 12: 980-983.
38.
Bennett RM et al. Group treatment of fibromyalgia: description and results of a 6 month out patient program. J Rheumatol1996; 23: 521-528.
39.
Bennett RMMultidisciplinary group programs to treat fibromyalgia patients. Goldenberg DL (ed). WB Saunders Co.: Philadelphia, 1996, pp 351.
40.
Burckhardt CS, Clark SR, Bennett RMFibromyalgia and quality of life: A comparative analysis. J Rheumatol1993; 20: 475-479.
Pellegrino MJAtypical chest pain as an initial presentation of primary fibromyalgia. Arch Phys Med Rehabil1990; 71: 526-528.
43.
Yunus MB, Aldag JCRestless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ1996; 312: 1339.
44.
Caidahl K. et al. Dyspnoea in chronic primary fibromyalgia. J Intern Med1989; 226: 265-270.
45.
Blasberg B. , Chalmers A.Temporomandibular pain and dysfunction syndrome associated with generalized musculoskeletal pain: a retrospective study. J Rheumatol Suppl1989; 19: 87-90.
46.
Gerster JC, Hadj Djilani A.Hearing and vestibular abnormalities in primary fibrositis syndrome. J Rheumatol1984; 11: 678-680.
47.
Burckhardt CS et al. Assessing depression in fibromyalgia patients. Arthritis Care Res1994; 7: 35-39.
48.
Yunus M. et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum1981; 11: 151-171.
49.
Wallace DJGenitourinary manifestations of fibrositis: An increased association with the female urethral syndrome. J Rheumatol1990; 17: 238-239.
50.
Gruber AJ, Hudson JI, Pope HG, Jr. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am1996; 19: 351-369.
51.
Veale D., Kavanagh G., Fielding JF, Fitzgerald O.Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol1991; 30: 220-222.
Sivri A., Cindas A., Dincer F., Sivri B.Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clin Rheumatol1996; 15: 283-286.
54.
Henriksson CMLongterm effects of fibromyalgia on everyday life. A study of 56 patients. Scand J Rheumatol1994; 23: 36-41.
55.
Waylonis GW , Ronan PG, Gordon C.A profile of fibromyalgia in occupational environments. Am J Phys Med Rehabil1994; 73: 112-115.
56.
Henriksson CMLiving with continuous muscular pain—patient perspectives. Part I: Encounters and consequences. Scand J Caring Sci1995; 9: 67-76.
57.
Moldofsky H.Chronobiological influences on fibromyalgia syndrome: theoretical and therapeutic implications. BaillieresClin Rheumatol1994; 8: 801-810.
58.
Mufson M., Regestein QRThe spectrum of fibromyalgia disorders [editorial; comment]. Arthritis Rheum1993; 36: 647-650.
59.
Croft P. et al. More pain, more tender points: is fibromyalgia just one end of a continuous spectrum?Ann Rheum Dis1996 ; 55: 482-485.
60.
Croft P., Schollum J., Silman A.Population study of tender point counts and pain as evidence of fibromyalgia . BMJ1994; 309: 696-699.
61.
Wolfe F. et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum1995; 38: 19-28.
62.
Bennett RMThe origin of myopain: An integrated hypothesis of focal muscle changes and sleep disturbance in patients with the fibromyalgia syndrome. J Musculoskeletal Pain1993; 1: 95-112.
Cohen ML, Quintner JLFibromyalgia syndrome, a problem of tautology. Lancet1993; 342: 906-909.
65.
Gibson SJ et al. Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome . Pain1994; 58: 185-193.
66.
Lorenz J., Grasedyck K., Bromm B.Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol1996; 100: 165-168.
67.
Coderre TJ, Katz J., Vaccarino AL, Melzack R.Contribution of central neuroplasticity to pathological pain: a review of clinical and experimental evidence. Pain1993 ; 52: 259-285.
68.
Dickenson AH , Sullivan AFNMDA receptors and central hyperalgesic states . Pain1991; 46: 344-345.
69.
Woolf CJ, Thompson SWThe induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain1991; 44: 293-299.
70.
Mendell LM, Wall PDResponse of single dorsal cord cells to peripheral cutaneous unmyelinated fibers. Nature1965; 206: 97—99.
71.
Dougherty PM , Willis WDEnhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain1992; 47: 85-93.
72.
Russell IJ et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum1994; 37: 1593-1601.
73.
Sorensen J. et al. Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine and ketamine. Scand J Rheumatol1995; 24: 360-365.
74.
Mountz JM et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum1995; 38: 926-938.
75.
Uveges JM et al Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum1990; 33: 1279-1283.
76.
Yunus MB, Ahles TA, Aldag JC, Masi ATRelationship of clinical features with psychological status in primary fibromyalgia . Arthritis Rheum1991; 34: 15-21.
77.
Boissevain MD, McCain GA. Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects. Pain1991; 45: 239-248.
78.
Yunus MBPsychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. BaillieresClin Rheumatol1994; 8: 811-837.
79.
Ercolani M. et al. Fibromyalgic syndrome: depression and abnormal illness behavior. Multicenter investigation. Psychother Psychosom1994; 61: 178-186.
80.
Birnie DJ et al. Psychological aspects of fibromyalgia compared with chronic and nonchronic pain. J Rheumatol1991; 18: 1845-1848.
81.
Merskey H.Physical and psychological considerations in the classification of fibromyalgia . J Rheumatol1989; 16 (suppl 19): 72-79.
82.
Aaron LA et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum1996; 39: 436-445.
83.
Merskey H. et al. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd Edn. IASP Press: Seattle, 1994.
84.
Hsieh JC et al. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain1995 ; 63: 225-236.
85.
Turk DCMeichenbaum D., Genest M.Pain and Behavioral Medicine: A Cognitive-Behavioral Perspective. Guildford: New York, 1983.
86.
Tan SYCognitive and cognitive-behavioral methods for pain control: a selective review . Pain1982; 12: 201-228.
87.
Bandura A. et al. Perceived self-efficacy and pain control: opioid and nonopioid mechanisms. J Pers Soc Psychol1987; 53: 563-571.
88.
Bandura A.Self-efficacy mechanism in physiological activation and health-promoting behavior . In: Madden JIV, Matthysse S, Barchas J (eds). Adaption, Leaning and Affect. Raven Press: New York, 1986.
89.
Flor H., Birbaumer N.Comparison of the efficacy of electromyographic biofeedback, cognitive-behavioral therapy, and conservative medical interventions in the treatment of chronic musculoskeletal pain. J Consult Clin Psychol1993; 61: 653-658.
90.
Sigal LHIllness behavior and the biomedical model. Bull Rheum Dis1997; 46: 1-4.